Daniel Markowitz CFA
Stock Analyst at Evercore ISI
(4.44)
# 1,179
Out of 4,675 analysts
63
Total ratings
63.6%
Success rate
26.7%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintained: Buy | $300 → $360 | $327.72 | +9.85% | 9 | Aug 7, 2026 | |
| PODD Insulet | Maintained: Buy | $180 | $145.42 | +23.78% | 6 | Aug 6, 2026 | |
| INSP Inspire Medical Systems | Maintained: Hold | $40 → $54 | $61.47 | -12.15% | 9 | Aug 4, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | $410 → $425 | $353.32 | +20.29% | 10 | Jul 27, 2026 | |
| RGEN Repligen | Maintained: Buy | $140 → $160 | $181.62 | -11.90% | 9 | Jul 6, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $118 → $90 | $93.60 | -3.85% | 6 | Jul 6, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $20 | $19.94 | +0.30% | 3 | Jun 5, 2026 | |
| TECH Bio-Techne | Rated: Hold | $54 → $50 | $72.39 | -30.93% | 6 | May 7, 2026 | |
| DXCM DexCom | Initiated Coverage: Hold | $68 | $91.06 | -25.32% | 1 | Nov 26, 2025 | |
| GH Guardant Health | Maintained: Buy | $68 → $90 | $163.18 | -44.85% | 4 | Oct 30, 2025 |
Natera
Aug 7, 2026
Maintained: Buy
Price Target: $300 → $360
Current: $327.72
Upside: +9.85%
Insulet
Aug 6, 2026
Maintained: Buy
Price Target: $180
Current: $145.42
Upside: +23.78%
Inspire Medical Systems
Aug 4, 2026
Maintained: Hold
Price Target: $40 → $54
Current: $61.47
Upside: -12.15%
West Pharmaceutical Services
Jul 27, 2026
Maintained: Buy
Price Target: $410 → $425
Current: $353.32
Upside: +20.29%
Repligen
Jul 6, 2026
Maintained: Buy
Price Target: $140 → $160
Current: $181.62
Upside: -11.90%
TransMedics Group
Jul 6, 2026
Maintained: Buy
Price Target: $118 → $90
Current: $93.60
Upside: -3.85%
MiniMed Group
Jun 5, 2026
Maintained: Buy
Price Target: $20
Current: $19.94
Upside: +0.30%
Bio-Techne
May 7, 2026
Rated: Hold
Price Target: $54 → $50
Current: $72.39
Upside: -30.93%
DexCom
Nov 26, 2025
Initiated Coverage: Hold
Price Target: $68
Current: $91.06
Upside: -25.32%
Guardant Health
Oct 30, 2025
Maintained: Buy
Price Target: $68 → $90
Current: $163.18
Upside: -44.85%